Tag

Bayer

All articles tagged with #bayer

Supreme Court Narrows Roundup Cancer Claims, Shifting Warnings to EPA
environment1 month ago

Supreme Court Narrows Roundup Cancer Claims, Shifting Warnings to EPA

The Supreme Court, in a 7-2 ruling, limited thousands of state lawsuits alleging Roundup caused cancer by holding that only the EPA can require warning labels, effectively preempting state actions. The decision follows reporting on Monsanto ghostwriting studies used in regulatory assessments; plaintiffs can press the EPA to reevaluate, but thousands of cases remain and billions have already been paid in settlements as investigations into the ghostwriting continue.

Supreme Court Roundup ruling triggers MAHA backlash over labeling
politics2 months ago

Supreme Court Roundup ruling triggers MAHA backlash over labeling

The Supreme Court’s 7-2 ruling means Bayer cannot be sued in state courts over Roundup because federal regulators have found glyphosate unlikely to cause cancer and thus do not require a warning label, potentially ending thousands of state lawsuits. MAHA leaders say the decision betrays their movement and are pressing Congress to curb pesticide-liability protections, as scientists and regulators remain divided on glyphosate’s cancer risk (EPA vs. IARC).

politics5 months ago

Bayer’s glyphosate gamble wins White House backing amid MAHA backlash

Bayer warned the White House it could pull Roundup from the U.S. market if regulators didn’t reassure MAHA and farmers; after the MAHA report spotlighted glyphosate as a health concern, the White House signaled support for keeping the product by backing an executive order to boost domestic glyphosate production and approving Bayer’s phosphorus mining permit, a move praised as national‑security‑driven but criticized by MAHA and activists who fear profits over safety.

Trump shields glyphosate production with executive order amid lawsuits
politics6 months ago

Trump shields glyphosate production with executive order amid lawsuits

President Trump signed an executive order under the Defense Production Act to secure domestic production of glyphosate-based herbicides like Roundup and elemental phosphorus, granting immunity to manufacturers and arguing the move is essential to national security and food supply. Health and environmental groups criticize it amid thousands of lawsuits alleging cancer risks, while Bayer says it will comply and pursues preemption in courts; the policy could affect litigation as a Supreme Court preemption case awaits in April.

Bayer tees up $7.25B settlement to wrap Roundup cancer lawsuits
business6 months ago

Bayer tees up $7.25B settlement to wrap Roundup cancer lawsuits

Bayer and plaintiffs’ lawyers unveiled a proposed nationwide settlement of up to $7.25 billion to resolve more than 125,000 U.S. Roundup cancer lawsuits, funded over as many as 21 years with payouts varying by exposure and age. The deal, which still needs Missouri court approval, would provide compensation even if the Supreme Court sides with Bayer on labeling preemption, while potentially shielding the company from larger future costs. Separately, Bayer has halted glyphosate in U.S. residential markets but continues its use in agriculture; regulators say glyphosate is unlikely to be carcinogenic when used as directed. Some plaintiffs’ attorneys say payouts are too small and opt-outs could derail the agreement.),

Bayer promotes $7.25B plan to settle Roundup lawsuits without admitting fault
business6 months ago

Bayer promotes $7.25B plan to settle Roundup lawsuits without admitting fault

Bayer's Monsanto unit proposed a $7.25 billion settlement to resolve Roundup non-Hodgkin lymphoma lawsuits, with annual payments over up to 21 years if approved; the deal includes no admission of liability and would lift Bayer's total litigation liability to about €11.8 billion, plus roughly €3 billion in other Roundup settlements. The lawsuits stem from Bayer's 2018 acquisition of Monsanto, and Roundup remains on the market as Bayer maintains its safety claims.

Supreme Court to decide Bayer’s bid to block thousands of Roundup lawsuits
law7 months ago

Supreme Court to decide Bayer’s bid to block thousands of Roundup lawsuits

The Supreme Court agreed to hear Bayer’s appeal aimed at blocking thousands of state lawsuits alleging the Roundup weedkiller causes cancer, weighing whether EPA approval without a cancer warning should defeat the claims. The Trump administration backs Bayer, reversing the Biden administration, while EPA officials say glyphosate is unlikely to be carcinogenic when used as directed. Bayer has set aside about $16 billion to settle claims and has pushed for state-level immunity laws, with Georgia and North Dakota enacting such measures. A Missouri case involving non-Hodgkin’s lymphoma is part of the docket, and Bayer faces roughly 181,000 claims overall. A 2024 appellate ruling favored Bayer, and the company has signaled it could remove glyphosate from U.S. residential markets but would retain it for agriculture; timing for arguments remains uncertain.

Bayer Faces Supreme Court Test Over Roundup Liability Preemption
business7 months ago

Bayer Faces Supreme Court Test Over Roundup Liability Preemption

The US Supreme Court agreed to hear Bayer AG’s appeal challenging thousands of Roundup lawsuits, focusing on whether federal pesticide law preempts state-level failure-to-warn claims. Bayer seeks to dismiss many cases while still facing roughly 67,000 claims, with billions already paid in verdicts and settlements and more reserved. The ruling could harmonize preemption standards across courts and impact the trajectory of Roundup litigation.